Compare Blackrock Inc (BLK) vs Moderna, Inc. (MRNA) Price & Performance

Blackrock IncTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Blackrock Inc vs Moderna, Inc. — how do they compare? Blackrock Inc trades at $1,145.5 (market cap $177.92B), while Moderna, Inc. trades at $60.53 (market cap $24.18B). The key difference: Blackrock Inc is far larger — about 7.4× Moderna, Inc.'s market cap, and Blackrock Inc pays a 2% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

	BLK	MRNA
Market Cap	$177.92B	$24.18B
Volume	641,547	—
Sector	Financials	Health
52-Week High	$1.20K	$81.80
52-Week Low	$922.90	$22.36
Enterprise Value	$179.02B	$20.33B
Dividend Yield	2%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BLK

Nio shares drop 5% after BlackRock reduces stake despite strong delivery growth.24/7 Wall Street · 1 day agoBearish Nvidia leads $500B Wall Street consortium to finance AI infrastructure expansion.24/7 Wall Street · 1 day agoBullish Wall Street giants plan $500B to finance AI infrastructure as a new asset class, says Nvidia CEO.CNBC · 1 day agoBullish View details →

MRNA

View details →

About Blackrock Inc

BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.